CClinicalTrials.gg
CompletedNCT05254678EmpowerUpdated Feb 5, 2026

Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy

An interventional study of general exercise in Breast Cancer and Upper Extremity Dysfunction, sponsored by University of Alberta. Completed at 1 site in Canada. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by University of Alberta · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The primary purpose of this study is to determine the feasibility of our proposed intervention approach involving (1) an integrated physiotherapy and exercise intervention for individuals with breast cancer who are undergoing chemotherapy and (2) delivery of programming via an electronic health (eHealth) application. The secondary objective is to determine the efficacy of the program on upper extremity outcomes, general physical fitness, cancer treatment-related symptoms and quality of life.

Read the detailed description

EMPOWER is a multi-methods feasibility randomized controlled trial. The study will recruit a minimum of 30 individuals with breast cancer who are undergoing adjuvant chemotherapy following surgery for breast cancer. The study will be conducted in two phases:

Phase I: Randomized Controlled Feasibility Trial The aim of this phase is to determine the feasibility and preliminary efficacy of a 10-week integrated physiotherapy and exercise intervention compared to an exercise intervention alone.

Phase II: Qualitative Study The aim of this phase is to evaluate the acceptability of the Healthy Eating, Active Living and Mindful Energy (HEAL-ME) Research App design, program delivery, program components and perceived effectiveness of the intervention at the level of the participant.

PHASE I: Randomized Controlled Feasibility Trial A randomized controlled trial design will be used to randomize individuals with breast cancer to one of two groups: 1) Comparison group: general exercise intervention + education; and 2) Experimental group: integrated physiotherapy and general exercise intervention + education. The study will be carried out over a 10-week period. The outcome measures will be assessed at baseline and at 10 weeks.

Randomization: An independent researcher will generate the randomization sequence using a computer-generated randomization module within the Trial's REDCap database. Randomization will occur following baseline testing.

Interventions:

Group 1 (Comparator): Hybrid In-Persona and HEAL-ME delivered General Exercise:

Participants in this group will take part the general exercise program delivered in-person and through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions in-person or virtually (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application. Exercise regimen: The exercise regimen follows the general principles of overload, progression, and specificity. The exercise program consists of full body exercise (e.g., comprising aerobic, resistance training, core stability, balance and flexibility training) a minimum of 2 times per week (one group virtual session and one independent self-directed session). Education: educational materials in written (PDF format) will be included in the Education module: resources section of the HEAL-ME application. Topics include the exercise expectations, behavior change strategies, home exercise equipment and how to exercise safely.

Group 2 (Experimental): Hybrid in-person and HEAL-ME Integrated Physiotherapy and exercise:

Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered in-person and through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions in-person or virtually, (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules. Integrated physiotherapy and exercise regimen: The integrated physiotherapy and exercise regimen will follow the exercise regimen as described in Group 1. For this group, breast cancer specific shoulder range of motion and stretching exercises will be incorporated into the warm-up and cool-down components of both group and individual exercise sessions. Education: educational videos will be available on the application and include topics such as cancer-related fatigue, risk reduction for lymphedema and pelvic health after breast cancer.

Educational materials in written (PDF format) will be included in the Education module: resources section of the HEAL-ME application. Topics include the benefits of exercise during chemotherapy for breast cancer, exercise behavior change strategies, and how to exercise safely.

Blinding An independent assessor, who is blinded to the group assignment will carry out all the measurements. Training of the assessor will be conducted on the measurement procedures related to the upper body and fitness outcome measurement protocols prior to study initiation.

PHASE II: Assessment of HEAL-ME App Design, Acceptability, and Program Components The app design, acceptability, and program components will be assessed following completion of the study through focus groups and semi-structured interviews to explore the experiences of individuals randomized to the HEAL-ME experimental group. The purpose of this phase is to assess different aspects of HEAL-ME related to the program delivery, different components contents, and time commitment. The results of this phase will inform further development of the HEAL- ME breast cancer module.

Phase II Data Collection Focus Groups: E-intervention group participants will be invited to participate in a focus group or semi-structured interview session that aim to capture participant perspectives and experiences, as well as any facilitators or barriers to use of the HEAL-ME application.

Qualitative Data Analysis The focus groups discussions will be audio recorded and transcribed. Two researchers will read and then reread the transcripts for accuracy against the audio recordings. The investigators will conduct an inductive content analysis to capture the participants' views about the program's acceptability and usability and ways to refine it. The inductive approach will enable a descriptive evaluation of the program from the participant's view. Two researchers will independently analyze the content of the focus group transcripts to identify evidence related to research objectives. Using the thematic analytic approach, the investigators will follow different processes described by Braun and Clarke. The data will be analyzed line by line by the researchers independently to identify patterns and key themes with example quotes from the data. Codes for similar meanings and highlighted terms will be developed, examined, and refined if necessary to identify the most expressive codes related to the research objectives. The process will be repeated a few times until concrete themes emerge and no further themes are identified. The generated themes will be reviewed and verified by a third researcher in order to increase the validity of the findings. Any coding discrepancies will be discussed and reconciled. Conceptual themes will be inductively originated from analysis through generating initial codes, followed by sub-themes, and finally, an overarching theme.

02

Conditions studied

  • Breast Cancer
  • Upper Extremity Dysfunction

Keywords

  • exercise
  • physical therapy
  • eHealth
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 32 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of Alberta is the lead sponsor of 800 studies on the registry; 168 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • adult females with a diagnosis of breast cancer (Stage Ic-III);
  • be able to participate in mild levels of activity at minimum;
  • have completed cancer surgery involving a mastectomy or breast conserving surgery involving either an axillary lymph node dissection or sentinel lymph node biopsy;
  • having completed or undergoing adjuvant chemotherapy +/- biological therapy treatment (eligible from 4 weeks to one year post-surgery at baseline);
  • speak and understand English.

Exclusion criteria

Exclusion Criteria:

  • unable to commit to the 10-week virtual program including testing sessions at the Cancer Rehabilitation clinic in the Corbett Hall at the University of Alberta;
  • do not have regular access to the internet and a smart device or computer in the home.
  • are scheduled to undergo neoadjuvant chemotherapy
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Standard exercise program

    Participants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application.

    Behavioral: general exercise

  • Experimental
    Integrated physiotherapy and exercise

    Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules.

    Behavioral: general exercise

Interventions

  • Behavioralgeneral exercise

    A 10-week integrated physiotherapy and general exercise intervention compared to a general exercise intervention alone.

    Also known as: physiotherapy

06

What researchers measure

Primary outcomes

  1. Completion rate

    Defined as \>70% participants completing at least 70% of exercise sessions and the post-study assessment

    Time frame: 10 weeks

Secondary outcomes

  1. Recruitment rate

    Percentage of participants eligible who consent to participate in the study

    Time frame: one year

  2. Attendance rate

    Percentage of completed exercise and education modules

    Time frame: 10 weeks

  3. Program Satisfaction

    Program Satisfaction Questionnaire

    Time frame: 10 weeks

  4. Symptoms

    Edmonton Symptom Assessment System

    Time frame: 10 weeks

  5. Health-related Quality of Life

    Functional Assessment of Cancer Therapy -breast (FACT-B+4)

    Time frame: 10 weeks

  6. Fatigue

    Functional Assessment of Cancer Therapy - fatigue subscale (FACIT-F)

    Time frame: 10 weeks

  7. Physical Activity

    Godin Leisure Time Exercise Questionnaire

    Time frame: 10 weeks

  8. Cost-effectiveness

    EuroQol 5-Dimension 5-Level (EQ-5D-5L)

    Time frame: 10 weeks

  9. Walking endurance

    Six-minute walk test

    Time frame: 10 weeks

  10. Lower body strength

    Thirty second sit-to-stand

    Time frame: 10 weeks

  11. Flexibility Shoulder Flexion

    Active Shoulder Range of Motion: flexion

    Time frame: 10 weeks

  12. Flexibility Shoulder Abduction

    Active Shoulder Range of Motion: abduction

    Time frame: 10 weeks

  13. Flexibility Shoulder External Rotation

    Active Shoulder Range of Motion: external rotation

    Time frame: 10 weeks

  14. Flexibility Shoulder Internal Rotation

    Active Shoulder Range of Motion: internal rotation

    Time frame: 10 weeks

  15. Flexibility Shoulder Horizontal Abduction

    Active Shoulder Range of Motion: horizontal abduction

    Time frame: 10 weeks

  16. Flexibility lower body

    Sit-and-reach

    Time frame: 10 weeks

  17. Balance

    One-leg Stance Test

    Time frame: 10 weeks

  18. Arm volume

    Perometry for the measurement of lymphedema

    Time frame: 10 weeks

  19. Body weight

    Measurement of weight in kgs

    Time frame: 10 weeks

  20. Body height

    Measurement of height in cms

    Time frame: 10 weeks

Other outcomes

  1. Grip strength (optional)

    Dynamometry

    Time frame: 10 weeks

  2. Core muscular endurance (optional)

    Plank endurance test

    Time frame: 10 weeks

07

Study locations

1 site
  • University of Alberta/ Cross Cancer Institute
    Edmonton, Alberta T6G 2G4, Canada
08

References and documents

Individual participant data

Plan to share: Yes — On completion of the trial, data will be available through the University of Alberta\'s Dataserve

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05254678
Lead sponsor
University of Alberta
Responsible party
Sponsor
First posted
Feb 24, 2022
Start date
Sep 20, 2023
Primary completion
Feb 6, 2024
Completion
Dec 30, 2024
Last update
Feb 5, 2026

Study contacts

Margaret McNeely
principal investigator · University of Alberta

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion